Figure 2b demonstrates differences in genotype distribution based on vaccine usage. RotaTeq is administered in Queensland, South Australia, Victoria and Western Australia. In locations using Rotarix; the dominant strain in RotaTeq states was G12P[8], representing 54% of all genotypes identified.